Mads Lamm Larsen

6PUBLICATIONS
26CO-AUTHORS
Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AutoimmunityInnate immunityHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 02, 2026
Real-world use of anifrolumab in systemic lupus erythematosus: A retrospective study from a Danish tertiary center (2022-2025).

Laura Nørgaard, Mads Lamm Larsen, Bent Deleuran

|Jan 13, 2025
Highlighting individual patient data related to chimeric antigen receptor T-cell therapy in refractory autoimmune rheumatic diseases.

M L Larsen, A Voss, C Tandrup Holst Nielsen

|Sep 09, 2024
Dangers of Herpesvirus Infection in SLE Patients Under Anifrolumab Treatment: Case Reports and Clinical Implications.

Mads Lamm Larsen, Morten Kelder Skouboe, Trine Hyrup Mogensen

|Jun 26, 2024
COVID-19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post-Pandemic Concerns About the Impact of Rituximab.

Christian Ammitzbøll, Marianne Kragh Thomsen, Lars Erik Bartels

|Jul 05, 2023
Differentiating between activation via the lectin or the classical complement pathway in patients with systemic lupus erythematosus.

Mads Lamm Larsen, Anne Troldborg, Erik J M Toonen

|Feb 15, 2018
Once- versus twice-daily aspirin treatment in patients with essential thrombocytosis.

Mads Lamm Larsen, Oliver Heidmann Pedersen, Anne-Mette Hvas

Pageof 1

Frequent Collaborators

4 joint publications

Anne Troldborg

2 joint publications

Ellen-Margrethe Hauge

1 joint publications

A Voss

1 joint publications

C Tandrup Holst Nielsen